Senior insider sale

COO and SVP, Compliance at ADMA BIOLOGICS, INC. — senior position signals high conviction

$155.4K

10.10K shares

What this filing means

KESTENBERG-MESSINA KAITLIN M. plans to sell 10.10K shares of ADMA BIOLOGICS, INC. valued at approximately $155.4K. Form 144 is a notice of intent to sell restricted or control securities — not a mandatory transaction. This filing provides advance warning of potential selling pressure.

KESTENBERG-MESSINA KAITLIN M.

Filed: 3/9/2026ACC: 0001140361-26-008523

InsiderKESTENBERG-MESSINA KAITLIN M.CIK 2017423

→

IssuerADMA BIOLOGICS, INC.CIK 1368514

Officer· COO and SVP, Compliance

Since Feb 2026

10.10K

Shares to sell

$155.4K

Approx. market value

10.10K

Acquired (3 months)

Planned

Securities Acquired — Last 3 Months5

Sort

Stock Option Exercise - Options Granted July 19, 2021

Cash

3/9/2026

2.17K

Stock Option Exercise - Options Granted February 14, 2017

Cash

3/9/2026

2.50K

Stock Option Exercise - Options Granted June 5, 2019

Cash

3/9/2026

1.25K

Stock Option Exercise - Options Granted February 25, 2021

Cash

3/9/2026

1.52K

Stock Option Exercise - Options Granted August 19, 2020

Cash

3/9/2026

2.65K

Total acquired10.10K

Acquisition Date	Type	Amount Acquired	Gift
3/9/2026	Stock Option Exercise - Options Granted July 19, 2021 Cash	2.17K	—
3/9/2026	Stock Option Exercise - Options Granted February 14, 2017 Cash	2.50K	—
3/9/2026	Stock Option Exercise - Options Granted June 5, 2019 Cash	1.25K	—
3/9/2026	Stock Option Exercise - Options Granted February 25, 2021 Cash	1.52K	—
3/9/2026	Stock Option Exercise - Options Granted August 19, 2020 Cash	2.65K	—
Total		10.10K

Planned & Completed Dispositions1

Sort

NASDAQPlanned

Units to sell

10.10K

Market value

$155.4K

3/9/2026

Total

Units

10.10K

Value

$155.4K

Date	Units to Sell	Approx. Market Value	Exchange	Status
3/9/2026	10.10K	$155.4K	NASDAQ	Planned
Total	10.10K	$155.4K